Flexing for Every Market Condition, Even a Pandemic
The rush to recommend an unproven drug for COVID-19 led to shortages or unnecessary expense for patients who actually benefit from it. Once again, our solution and support team stepped up.
The rush to recommend an unproven drug for COVID-19 led to shortages or unnecessary expense for patients who actually benefit from it. Once again, our solution and support team stepped up.